CDC42BPA inhibition for high-grade serous ovarian carcinoma

By Claire Quang | Apr 2, 2020 | 7:25 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Ovarian cancer

Inhibition of CDC42BPA alone or in combination with carboplatin and PAK1 inhibition could

Read the full 179 word article

How to gain access

Continue reading with a
two-week free trial.